SEC Filings

Scroll right

Artelo Biosciences ARTL is currently traded on Nasdaq.

The Company announces material financial information to its investors using SEC filings, press releases, public webcasts and conference calls. This website is intended to communicate with subscribers, shareholders and the public about the Company, its ongoing research and development, and other corporate matters that are in the public domain. To comply with Regulation FD disclosure obligations, the Company also aims to link to social media channels from this website for disclosure of information about Artelo, our technology, and activities, as well as to share educational content related to our products and technology.